Skip to Main
Data science in pharmaceutical R&D: the DISRUPT-DS industry roundtable |Hero

Data Science in Pharmaceutical R&D: The DISRUPT-DS Industry Roundtable

Najat S. Khan Thomas Senderovitz James Weatherall Janice Branson Benedikt Egersdoerfer Eric Genevois -Marlin Sai Jasti Mustaqhusain Kazi Ranjit Kumble Patrick Loerch Justine Rochon Venkat Sethuraman Matt Studney Xiaoying Wu Ryan Copping Priya Chandran Madura Jayatunga Dhruv Jayanth Christoph Meier

The DISRUPT-DS roundtable is an initiative which brings together data science leaders from large pharmaceutical companies. It is a forum for sharing experiences and networking, for shaping industry-level topics and for amplifying the role of data science across pharmaceutical R&D.

Pharmaceutical R&D is undergoing unprecedented change. One of the most exciting changes is the increasing use of data science, especially AI, which promises to improve R&D efficiency, to support decision making, to deliver scientific innovation and ultimately to bring new medicines to patients faster.

As the use of data science accelerates, it has become clear that the industry needs a forum for leaders to connect and collectively drive innovation across companies. The DISRUPT-DS roundtable aims to be that forum.

Participants of the roundtable have recently published a paper, in Nature Reviews Drug Discovery, in which we discuss the current state of data science across the industry, opportunities and challenges going forward, and the role which the DISRUPT-DS roundtable intends to play.